Shirinezhad Amirhossein, Azarboo Alireza, Ghaseminejad-Raeini Amirhossein, Kanaani Nejad Fatemeh, Zareshahi Negar, Amiri Sheyda Mohtasham, Tahmasebi Yasamin, Hoveidaei Amir Human
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Front Endocrinol (Lausanne). 2024 Dec 18;15:1499479. doi: 10.3389/fendo.2024.1499479. eCollection 2024.
The relationship of insulin resistance with bone mineral density (BMD) remains unclear, offering an opportunity for novel indices to shed light on the matter. The aim of this review was to evaluate the association between surrogate indices of insulin resistance and BMD.
A systematic review was conducted to evaluate observational studies that examined the relationship between insulin resistance surrogate indices and BMD in adults. Databases including PubMed, Web of Science, Scopus, and Embase were searched. Quality assessment was performed using Joanna Briggs Institute (JBI) critical appraisal tools.
This systematic review included 27 cohorts and cross-sectional studies with 71,525 participants to assess the potential link between insulin resistance surrogate indices like HOMA-IR, HOMA-β, TyG, TyG-BMI, TyG-WtHR, and TyG-WC, along with METS-IR, and VAI, and BMD at various sites. There seems to be no link between BMD and the HOMA index, despite being extensively studied in various studies (adjusted β ranging from -0.49 to 0.103). Most literature suggests that a higher TyG index is associated with decreased BMD levels (adjusted β ranging from -0.085 to 0.0124). Despite limited evidence, other insulin resistance indices such as VAI (adjusted β ranging from 0.007 to 0.016), TyG-BMI (adjusted β ranging from 0.002 to 0.415), METS-IR (adjusted β ranging from 0.005 to 0.060), TyG-WtHR (β = 0.012) and TyG-WC (β = 0.0001) have shown a positive association with BMD in a few studies.
This systematic review emphasizes the intricate connection between insulin resistance and BMD. The lack of ability to perform a meta-analysis and the dependence on cross-sectional studies hinder the robustness of the findings, hence necessitating well-designed longitudinal studies.
https://www.crd.york.ac.uk/prospero/, identifier CRD42024512770.
胰岛素抵抗与骨密度(BMD)之间的关系仍不明确,这为新的指标揭示该问题提供了契机。本综述的目的是评估胰岛素抵抗替代指标与骨密度之间的关联。
进行了一项系统综述,以评估观察性研究,这些研究考察了成人胰岛素抵抗替代指标与骨密度之间的关系。检索了包括PubMed、科学网、Scopus和Embase在内的数据库。使用乔安娜·布里格斯研究所(JBI)的批判性评价工具进行质量评估。
本系统综述纳入了27项队列研究和横断面研究,共71525名参与者,以评估胰岛素抵抗替代指标如稳态模型评估胰岛素抵抗(HOMA-IR)、稳态模型评估β细胞功能(HOMA-β)、甘油三酯与葡萄糖比值(TyG)、TyG-体重指数(TyG-BMI)、TyG-腰臀比(TyG-WtHR)和TyG-腰围(TyG-WC),以及代谢综合征胰岛素抵抗指数(METS-IR)和内脏脂肪指数(VAI)与不同部位骨密度之间的潜在联系。尽管在各种研究中对HOMA指数进行了广泛研究,但骨密度与HOMA指数之间似乎没有联系(调整后的β值范围为-0.49至0.103)。大多数文献表明,较高的TyG指数与较低的骨密度水平相关(调整后的β值范围为-0.085至0.0124)。尽管证据有限,但其他胰岛素抵抗指标,如VAI(调整后的β值范围为0.007至0.016)、TyG-BMI(调整后的β值范围为0.002至0.415)、METS-IR(调整后的β值范围为0.005至0.060)、TyG-WtHR(β = 0.012)和TyG-WC(β = 0.0001)在一些研究中显示与骨密度呈正相关。
本系统综述强调了胰岛素抵抗与骨密度之间的复杂联系。无法进行荟萃分析以及对横断面研究的依赖阻碍了研究结果的稳健性,因此需要设计良好的纵向研究。